Medibank Private (MPL.AX) Azione Prezzo
Medibank Private Prezzo
Il fatturato è cresciuto a un tasso composto del 5,8% annuo negli ultimi 19 anni, raggiungendo 9,33 miliardi AUD. L'utile per azione è cresciuto del 8,1% all'anno negli ultimi 13 anni. Il margine netto di Medibank Private si attesta al 6,8%, in aumento rispetto al 5,6% di alcuni anni fa. Medibank Private offre attualmente un rendimento da dividendo di circa il 2,31%. Il payout ratio è pari a circa il 129% degli utili. Il dividendo è cresciuto del 4,2% all'anno negli ultimi 11 anni. Gli analisti fissano un target di prezzo mediano di 5,00 AUD, ovvero il 2,8% sotto il prezzo attuale. Su 14 analisti, 5 valutano il titolo come acquisto — nel complesso un consenso Mantenere.
Medibank Private Prezzo delle azioni
Accedi a questi dati tramite l’API Eulerpool
100.000 richieste/mese gratis · nessuna carta di credito
Medibank Private Azione e analisi azionaria
Domande frequenti sull'azione Medibank Private
Medibank Private Ltd operates as a leading private health insurance provider in Australia. The company's business model revolves around offering health insurance products and services to a wide range of individuals and families. Medibank Private aims to ensure accessibility, affordability, and quality healthcare for its customers. The company's model focuses on providing comprehensive coverage, including hospital treatment, specialist consultations, and ancillary services. By leveraging its extensive network of healthcare providers and utilizing advanced technological solutions, Medibank Private delivers value-based and customer-centric healthcare solutions. With a strong emphasis on innovation and customer satisfaction, Medibank Private continues to serve as a reliable and trusted health insurance partner.
Medibank Private Ltd is primarily active in the healthcare industry.
The main competitors of Medibank Private Ltd in the market include Bupa Australia, HCF, NIB Holdings Ltd, and HBF Health Limited.
Medibank Private Ltd is an Australian private health insurance company. It was established in 1976 as a government-owned entity to provide affordable health coverage to Australians. Initially, it operated as a not-for-profit organization until it was privatized in 2014 and listed on the Australian Securities Exchange (ASX). Since then, Medibank has evolved into a leading health insurer, offering a wide range of health insurance products and services to individuals, families, and businesses across Australia. With a strong focus on customer satisfaction and innovative healthcare solutions, Medibank Private Ltd continues to play a vital role in ensuring the well-being of millions of Australians.
Medibank Private Ltd, Australia's leading health insurer, has achieved several significant milestones throughout its history. One of the key achievements was its successful initial public offering (IPO) in 2014, marking its transition from a government-owned entity to a publicly listed company. Since then, Medibank has consistently delivered strong financial performance, demonstrating its commitment to shareholder value. The company has also expanded its services by introducing innovative healthcare programs and partnerships, aimed at improving the health and well-being of its members. Medibank's focus on customer satisfaction and high-quality healthcare has enabled it to become a trusted name in the industry, further reinforcing its position as a market leader.
Medibank Private Ltd is primarily present in Australia. This leading private health insurance provider operates predominantly in its home country, catering to a wide customer base. With its headquarters located in Melbourne, Medibank Private Ltd offers a range of health insurance services and products to individuals, families, and businesses across Australia.
Medibank Private Ltd represents a commitment to delivering high-quality healthcare services to its customers. The company values customer satisfaction and aims to provide accessible and affordable healthcare for all Australians. Medibank Private Ltd places importance on innovation, investing in new technologies and approaches to improve healthcare outcomes. With a focus on corporate responsibility, the company aims to make a positive impact on the health and wellbeing of individuals and communities. Medibank Private Ltd strives to be a trusted and customer-centric healthcare provider, ensuring the utmost care and support for its customers' health needs.
Gli analisti fissano attualmente un prezzo obiettivo medio di 5,22 AUD per l’azione Medibank Private (mediana: 5,00 AUD), pari a +2,0 % rispetto all’ultimo prezzo. Il consenso si basa su 14 giudizi di analisti.
14 analisti valutano attualmente l’azione Medibank Private: 5 raccomandano l’acquisto, 9 la tenuta e 0 la vendita.
Convertita al tasso di cambio attuale, l’azione Medibank Private quota 3,20 EUR (5,14 AUD).
L’azione Medibank Private (MPL.AX) è quotata su 5 borse, tra cui: SIX (Zürich) (MPV.SW), ASX (MPL.AX), Frankfurt (MPV.F), München (MPV.MU), Düsseldorf (MPV.DU).
Medibank Private Ltd is a leading Australian health insurance company that provides its customers with high-quality health solutions and medical services. The company operates in four main areas: health insurance, health services, private hospitals, and life insurance. It offers a wide range of health insurance products and services, including individual and family plans, group plans for businesses, and a variety of health services such as home visits, telemedicine, and emergency services. The private hospital division provides access to top-notch facilities and medical services. The company also offers life insurance products and services, including life insurance, income protection insurance, and accident insurance. Medibank Private aims to improve the customer experience through innovative technologies and digital services, offering tools and applications to manage and improve health and lifestyle. Overall, Medibank Private has a strong business model focused on providing high-quality health solutions and medical services, with a strong market position and a commitment to expanding its product and service offerings to meet the changing needs of its customers.
Il fatturato di Medibank Private ammonta a 9,33 miliardi AUD. Questo dato si basa sui dati finanziari attuali e riflette lo sviluppo commerciale dell'azienda.
Il profitto di Medibank Private ammonta a 638,70 Mio. AUD. L'utile netto riflette la redditività dell'azienda dopo la deduzione di tutti i costi.
Il rapporto prezzo/utili (P/E) di Medibank Private è attualmente 22,16. Il rapporto P/E confronta il prezzo attuale dell'azione con l'utile per azione e aiuta gli investitori a valutare la valutazione dell'azione Medibank Private.
Il rapporto prezzo/fatturato (P/S) di Medibank Private è attualmente 1,52. Il rapporto P/S confronta la capitalizzazione di mercato con il fatturato annuo e funge da indicatore di valutazione dell'azione Medibank Private.
Il Quality Score AlleAktien per Medibank Private è 7/10.
L'ISIN di Medibank Private è AU000000MPL3. L'ISIN (International Securities Identification Number) è un codice identificativo univoco a livello mondiale per i titoli.
Il WKN di Medibank Private è A12D1W. Il WKN (Wertpapierkennnummer) è un codice identificativo tedesco a sei cifre per i titoli.
Il ticker di Medibank Private è MPL.AX. Con questo simbolo di borsa vengono negoziate le azioni Medibank Private in borsa.
Azione Medibank Private
Gruppo di pari di Medibank Private
Medibank Private Ticker
Medibank Private FIGI
Altre metriche e analisi di Medibank Private in Deep Dive.
La nostra analisi azionaria dell'azione Medibank Private include importanti indicatori finanziari come il fatturato, l'utile, il P/E, il P/S, l'EBIT, oltre a informazioni sul dividendo. Inoltre, esaminiamo aspetti come le azioni, la capitalizzazione di mercato, il debito, il patrimonio netto e le passività di Medibank Private. Se state cercando informazioni più dettagliate su questi temi, sulle nostre sottopagine offriamo analisi approfondite: